Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学EGFR Exon 20 Insertion Lung Cancer

Gregory Riely

MD, PhD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Chief, Thoracic Oncology Service

95
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Gregory Riely leads the thoracic oncology service at MSKCC and has made seminal contributions to EGFR exon 20 insertion biology. His clinical trials have helped establish the efficacy of next-generation EGFR inhibitors in this patient population. He is a key advocate for expanded molecular testing in lung cancer.

Share:

🧪Research Fields 研究领域

EGFR exon 20 insertions
NSCLC molecular profiling
Clinical trial design
Targeted therapy
Lung cancer genomics

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Gregory Riely 的研究动态

Follow Gregory Riely's research updates

留下邮箱,当我们发布与 Gregory Riely(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment